Showing results (401-410 of 585) with videos related to

Sort By:
Pageof 59
Clinical Journal of Gastroenterology|July 21, 2015
Severe hypoglycemia associated with insulin-like growth factor II-producing liver metastasis from gastric carcinoma treated with overnight total parenteral nutrition via a central vein catheter reserve portYohei Koizumi, Atsushi Hiraoka, Kojiro Michitaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 30, 2022
Significant association between HLA-B*35:01 and onset of drug-induced liver injury caused by Kampo medicines in Japanese patientsRyosuke Nakamura, Noriaki Arakawa, Yoichi Tanaka, et al.
Internal Medicine (Tokyo, Japan)|June 3, 2016
A Possible Case of Hepatitis due to Hypereosinophilic SyndromeTomoe Kawamura, Atsushi Hiraoka, Akiko Toshimori, et al.
Journal of Gastroenterology|November 15, 2024
Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapyTakao Watanabe, Yoshio Tokumoto, Hironori Ochi, et al.
Internal Medicine (Tokyo, Japan)|March 17, 2020
ABO Blood Type and the Long-term Outcomes of Pancreatic CancerYoshinori Tanaka, Teru Kumagi, Takashi Terao, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 16, 2019
Zinc deficiency as an independent prognostic factor for patients with early hepatocellular carcinoma due to hepatitis virusAtsushi Hiraoka, Kensuke Nagamatsu, Hirofumi Izumoto, et al.
Journal of Medical Virology|March 2, 2011
Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2bNaoya Sakamoto, Mina Nakagawa, Yasuhito Tanaka, et al.
Hepato-Gastroenterology|August 12, 2011
Hepatic resection assisted by ablative therapy for advanced hepatocellular carcinomaAtsushi Hiraoka, Nayu Tazuya, Satoshi Hidaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 17, 2026
Fibrosis-4 Index as a Robust Long-Term Predictor of Cancers in Metabolic Dysfunction-Associated Steatotic Liver DiseaseAyumi Kanamoto, Teruki Miyake, Shinya Furukawa, et al.
Internal Medicine (Tokyo, Japan)|July 31, 2022
Clinical Outcomes of S-1 Monotherapy and Modified FOLFIRINOX Therapy after Gemcitabine plus Nab-paclitaxel Therapy in Unresectable Pancreatic CancerKaori Hino, Tomohiro Nishina, Yuuki Numata, et al.
Pageof 59